Atlas Trials

Open Label Comparative Study Of De Novo Renal Allograft Recipients Receiving CSA + MMF + Corticosteroids Versus CSA + Rapamune + Corticosteroids

Clinical trial NCT01601821 · COMPLETED

Trial details

NCT number
NCT01601821
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Inflammation
Start date
2006-04-01
Primary completion
2008-03-01
Enrollment
245

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.